dactinomycin and Tumor Lysis Syndrome

dactinomycin has been researched along with Tumor Lysis Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kube, P; Mangum, DS; Parisio, K; Powell, J	1

Other Studies

1 other study(ies) available for dactinomycin and Tumor Lysis Syndrome

Article	Year
Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity. BMJ case reports, 2022, Aug-29, Volume: 15, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Genital Neoplasms, Male; Humans; Male; Rhabdomyosarcoma; Rhabdomyosarcoma, Embryonal; Tumor Lysis Syndrome; Vincristine	2022

Article

Year

Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity.

BMJ case reports, 2022, Aug-29, Volume: 15, Issue:8

Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Genital Neoplasms, Male; Humans; Male; Rhabdomyosarcoma; Rhabdomyosarcoma, Embryonal; Tumor Lysis Syndrome; Vincristine

2022